Literature DB >> 24905057

Protecting our Khmer daughters: ghosts of the past, uncertain futures, and the human papillomavirus vaccine.

Nancy J Burke1, Huyen H Do, Jocelyn Talbot, Channdara Sos, Srey Ros, Victoria M Taylor.   

Abstract

OBJECTIVES: The FDA approved the first human papillomavirus (HPV) vaccine in 2006. Research into parental decision-making and concerns about HPV vaccination highlights questions about parenting and parents' role in the crafting of their daughters' future sexuality. In contrast to much of this literature, we explore narratives from interviews with Cambodian mothers of HPV vaccine-age eligible daughters who experienced genocide and came to the USA as refugees.
DESIGN: We conducted in-depth, in-person interviews with 25 Cambodian mothers of HPV vaccine-age eligible daughters. Interviews were conducted in Khmer and translated into English for analysis. We followed standard qualitative analysis techniques including iterative data review, multiple coders, and 'member checking.' Five members of the research team reviewed all transcripts and two members independently coded each transcript for concepts and themes.
RESULTS: Interview narratives highlight the presence of the past alongside desires for protection from uncertain futures. We turn to Quesada and colleagues' concept structural vulnerability to outline the constraints posed by these women's positionalities as genocide survivors when faced with making decisions in an area with which they have little direct knowledge or background: cervical cancer prevention.
CONCLUSION: Our study sheds light on the prioritization of various protective health practices, including but not exclusive to HPV vaccination, for Khmer mothers, as well as the rationalities informing decision-making regarding their daughters' health.

Entities:  

Keywords:  Cambodian immigrants; HPV; cervical cancer; uncertainty

Mesh:

Substances:

Year:  2014        PMID: 24905057      PMCID: PMC4258177          DOI: 10.1080/13557858.2014.921895

Source DB:  PubMed          Journal:  Ethn Health        ISSN: 1355-7858            Impact factor:   2.772


  21 in total

1.  Cervical cancer incidence in a prevaccine era in the United States, 1998-2002.

Authors:  Mona Saraiya; Faruque Ahmed; Sheila Krishnan; Thomas B Richards; Elizabeth R Unger; Herschel W Lawson
Journal:  Obstet Gynecol       Date:  2007-02       Impact factor: 7.661

2.  Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis.

Authors:  Norman A Constantine; Petra Jerman
Journal:  J Adolesc Health       Date:  2006-12-06       Impact factor: 5.012

3.  Evaluation of an outreach intervention to promote cervical cancer screening among Cambodian American women.

Authors:  Victoria M Taylor; J Carey Jackson; Yutaka Yasui; Alan Kuniyuki; Elizabeth Acorda; Ann Marchand; Stephen M Schwartz; Shin-Ping Tu; Beti Thompson
Journal:  Cancer Detect Prev       Date:  2002

4.  Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

Authors:  Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

5.  Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.

Authors:  Amanda F Dempsey; Gregory D Zimet; Robert L Davis; Laura Koutsky
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

6.  Parental acceptance of the human papillomavirus vaccine.

Authors:  Elyse Olshen; Elizabeth R Woods; S Bryn Austin; Marlise Luskin; Howard Bauchner
Journal:  J Adolesc Health       Date:  2005-09       Impact factor: 5.012

7.  Human papillomavirus: epidemiology and public health.

Authors:  Mark Schiffman; Philip E Castle
Journal:  Arch Pathol Lab Med       Date:  2003-08       Impact factor: 5.534

Review 8.  Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.

Authors:  Cosette M Wheeler
Journal:  Nat Clin Pract Oncol       Date:  2007-04

9.  Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.

Authors:  Kevin A Ault
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321

10.  High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

Authors:  L L Villa; R L R Costa; C A Petta; R P Andrade; J Paavonen; O-E Iversen; S-E Olsson; J Høye; M Steinwall; G Riis-Johannessen; A Andersson-Ellstrom; K Elfgren; G von Krogh; M Lehtinen; C Malm; G M Tamms; K Giacoletti; L Lupinacci; R Railkar; F J Taddeo; J Bryan; M T Esser; H L Sings; A J Saah; E Barr
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

View more
  2 in total

Review 1.  Refugees, asylum-seekers and undocumented migrants and the experience of parenthood: a synthesis of the qualitative literature.

Authors:  Lisa Merry; Sandra Pelaez; Nancy C Edwards
Journal:  Global Health       Date:  2017-09-19       Impact factor: 4.185

2.  Socioecological Factors Influencing Sexual Health Experiences and Health Outcomes of Migrant Asian Women Living in 'Western' High-Income Countries: A Systematic Review.

Authors:  Corie Gray; Gemma Crawford; Bruce Maycock; Roanna Lobo
Journal:  Int J Environ Res Public Health       Date:  2021-03-03       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.